Kelly Lawrence W & Associates’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-407
Closed -$30.6K – 140
2025
Q3
$30.6K Hold
407
– – 0.01% 126
2025
Q2
$30.1K Hold
407
– – 0.01% 125
2025
Q1
$32.8K Hold
407
– – 0.01% 127
2024
Q4
$31.8K Sell
407
-41
-9% -$3.48K 0.01% 126
2024
Q3
$42K Hold
448
– – 0.01% 124
2024
Q2
$34.9K Buy
448
+41
+10% +$3.34K 0.01% 130
2024
Q1
$37K Hold
407
– – 0.01% 126
2023
Q4
$31.5K Sell
407
-181
-31% -$12.7K 0.01% 125
2023
Q3
$40K Hold
588
– – 0.01% 117
2023
Q2
$46.4K Hold
588
– – 0.01% 104
2023
Q1
$48.2K Buy
+588
New +$42K 0.01% 107

Other funds holding GEHC

Kelly Lawrence W & Associates's GEHC Position: Q4 2025 in Review

Kelly Lawrence W & Associates sold out of GE HealthCare (GEHC) in Q4 2025, closing a stake of 407 shares — an estimated $30.6K sold.

Kelly Lawrence W & Associates first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $48.2K in Q1 2023. 1,338 funds tracked by Wall St. Rank hold GEHC as of Q4 2025.

  • Kelly Lawrence W & Associates reported no remaining GE HealthCare position as of Q4 2025 after selling out during the quarter.
  • Kelly Lawrence W & Associates sold 407 GE HealthCare shares in Q4 2025, an estimated $30.6K.
  • Kelly Lawrence W & Associates first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
  • Kelly Lawrence W & Associates's GE HealthCare position peaked at $48.2K in Q1 2023.
  • 1,338 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2025.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2025, filed 17 Feb 2026.